An additional novel line of research opened by our study is the possible implication of AhR, as a new potent druggable target, in disorders in which cognitive deficits are accompanied by hippocampal morphologic alterations, such as epilepsy, schizophrenia, or stroke. This evidence concerns the gene AHR and Stroke.